new injectable biologic for moderate to severe plaque psoriasis called Stelara (stel-AR-a)
You'll soon hear about a new injectable biologic for moderate to severe plaque psoriasis called Stelara (stel-AR-a).
It's the first of a new class. It inhibits the inflammatory proteins interleukin-12 and -23...instead of tumor necrosis factor.
Some evidence suggests that Stelara might be more effective than Enbrel for psoriasis. But this isn't proven yet...and there are concerns about long-term safety.
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 200+ CE courses, including the popular CE-in-the-Letter
- Quick reference drug comparison charts
- Access to the entire archive
Already a subscriber? Log in
Volume pricing available. Get a quote